News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,567 Results
Type
Article (29844)
Company Profile (116)
Press Release (382607)
Section
Business (105728)
Career Advice (534)
Deals (18604)
Drug Delivery (80)
Drug Development (51467)
Employer Resources (79)
FDA (11479)
Job Trends (10341)
News (192082)
Policy (22004)
Tag
Academia (2139)
Alliances (29013)
Alzheimer's disease (938)
Approvals (11446)
Artificial intelligence (105)
Bankruptcy (153)
Best Places to Work (9181)
Biotechnology (65)
Breast cancer (81)
Cancer (678)
Cardiovascular disease (91)
Career advice (491)
Cell therapy (126)
Clinical research (42652)
Collaboration (263)
COVID-19 (2247)
Cystic fibrosis (57)
Data (771)
Diabetes (116)
Diagnostics (4752)
Drug pricing (84)
Earnings (35713)
Employer resources (70)
Events (73034)
Executive appointments (205)
FDA (11900)
Funding (253)
Gene therapy (106)
GLP-1 (398)
Government (4226)
Healthcare (15160)
Infectious disease (2327)
Inflammatory bowel disease (80)
Interviews (58)
IPO (7994)
Job creations (1510)
Job search strategy (448)
Layoffs (215)
Legal (3970)
Lung cancer (121)
Manufacturing (108)
Medical device (9470)
Medtech (9473)
Mergers & acquisitions (10686)
Metabolic disorders (307)
Neuroscience (1149)
NextGen Class of 2024 (5067)
Non-profit (3939)
Northern California (942)
Obesity (180)
Opinion (120)
People (32418)
Phase I (11335)
Phase II (17840)
Phase III (16450)
Pipeline (313)
Policy (57)
Postmarket research (1774)
Preclinical (3334)
Radiopharmaceuticals (150)
Rare diseases (170)
Real estate (2877)
Regulatory (14831)
Research institute (1937)
Southern California (764)
Startups (2121)
United States (8894)
Vaccines (474)
Weight loss (123)
Date
Today (99)
Last 7 days (503)
Last 30 days (2551)
Last 365 days (23786)
2024 (21795)
2023 (26326)
2022 (35789)
2021 (39257)
2020 (39397)
2019 (34739)
2018 (26062)
2017 (19358)
2016 (20014)
2015 (22890)
2014 (16964)
2013 (13268)
2012 (14045)
2011 (14494)
2010 (12571)
Location
Africa (522)
Arizona (95)
Asia (22735)
Australia (4109)
California (2015)
Canada (872)
China (167)
Colorado (105)
Connecticut (121)
Europe (50675)
Florida (299)
Georgia (100)
Illinois (233)
Indiana (183)
Kansas (73)
Maine (58)
Maryland (412)
Massachusetts (1591)
Michigan (103)
Minnesota (149)
New Jersey (731)
New York (651)
North Carolina (498)
Northern California (942)
Ohio (94)
Pennsylvania (578)
South America (679)
Southern California (764)
Texas (260)
Utah (75)
Washington State (275)
412,567 Results for "endpoint health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
October 1, 2024
·
6 min read
Press Releases
Adaptimmune’s Lete-cel Achieves Primary Endpoint in Pivotal Trial
November 13, 2024
·
8 min read
Drug Development
Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and pyruvate kinase activation pioneering therapies for rare diseases, announced that the global Phase 3 ENERGIZE-T study of mitapivat in adults with transfusion-dependent alpha- or beta-thalassemia achieved its primary endpoint of transfusion reduction response.
June 3, 2024
·
10 min read
Press Releases
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
November 19, 2024
·
19 min read
Press Releases
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
November 8, 2024
·
21 min read
Drug Development
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity.
June 24, 2024
·
9 min read
Press Releases
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
October 29, 2024
·
2 min read
Drug Development
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major secondary endpoints, including highly statistically significant rates of endoscopic remission
Johnson & Johnson announced the first data from the Phase 3 QUASAR Maintenance Study that showed 50.0 percent of patients with moderately to severely active ulcerative colitis receiving subcutaneous TREMFYA® 200 mg every four weeks and 45.2 percent of patients receiving SC TREMFYA® 100 mg every eight weeks achieved the primary endpoint of clinical remission at Week 44 compared to placebo.
May 20, 2024
·
14 min read
Press Releases
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
November 8, 2024
·
12 min read
Business
Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to Drive Adoption of Digital Endpoints in Clinical Trials
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced a partnership with the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe).
June 11, 2024
·
4 min read
1 of 41,257
Next